31st October 2013 at the Online Event in Palo Alto, US [6245]
This webinar on FDA Pharmacy Compounding will detail the current thinking, the efforts made and steps taken by FDA and legislatures since the meningitis outbreak in 2012. Why Should You Attend: Since the meningitis outbreak caused by contaminated compounded drugs, congressional hearings ensued and Congress has sought to pass legislation. Did you know that there are currently two versions of legislation in the works by the House of Representatives that attempt to clarify FDA’s authority?
Contact: Referral
Telephone: +1-650-620-3915; Fax: +1-650-963-2556
Email: referral@complianceonline.com
Website: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=703164?channel=pharmaorg
This webinar on FDA Pharmacy Compounding will detail the current thinking, the efforts made and steps taken by FDA and legislatures since the meningitis outbreak in 2012. Why Should You Attend: Since the meningitis outbreak caused by contaminated compounded drugs, congressional hearings ensued and Congress has sought to pass legislation. Did you know that there are currently two versions of legislation in the works by the House of Representatives that attempt to clarify FDA’s authority?
Contact: Referral
Telephone: +1-650-620-3915; Fax: +1-650-963-2556
Email: referral@complianceonline.com
Website: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=703164?channel=pharmaorg